Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity.

Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Niumsakul S, Bauer JA.

Basic Clin Pharmacol Toxicol. 2005 Jan;96(1):80-7.

2.

Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity.

Chularojmontri L, Wattanapitayakul SK, Herunsalee A, Charuchongkolwongse S, Niumsakul S, Srichairat S.

Biol Pharm Bull. 2005 Jul;28(7):1165-71.

3.

Evaluation of the potential cardioprotective activity of some Saudi plants against doxorubicin toxicity.

Ashour OM, Abdel-Naim AB, Abdallah HM, Nagy AA, Mohamadin AM, Abdel-Sattar EA.

Z Naturforsch C. 2012 May-Jun;67(5-6):297-307.

PMID:
22888535
4.
5.

Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.

Li W, Xu B, Xu J, Wu XL.

Basic Clin Pharmacol Toxicol. 2009 Mar;104(3):192-7. doi: 10.1111/j.1742-7843.2008.00358.x. Epub 2009 Jan 8.

6.

Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities.

Choi EH, Chang HJ, Cho JY, Chun HS.

Food Chem Toxicol. 2007 Oct;45(10):1873-81. Epub 2007 Apr 21.

PMID:
17524543
7.

Tomato-oleoresin supplement prevents doxorubicin-induced cardiac myocyte oxidative DNA damage in rats.

Ferreira AL, Salvadori DM, Nascimento MC, Rocha NS, Correa CR, Pereira EJ, Matsubara LS, Matsubara BB, Ladeira MS.

Mutat Res. 2007 Jul 10;631(1):26-35. Epub 2007 Apr 7.

PMID:
17499013
8.

Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats.

Alkreathy H, Damanhouri ZA, Ahmed N, Slevin M, Ali SS, Osman AM.

Food Chem Toxicol. 2010 Mar;48(3):951-6. doi: 10.1016/j.fct.2010.01.005. Epub 2010 Jan 12.

PMID:
20060872
9.

Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein.

Andreadou I, Papaefthimiou M, Zira A, Constantinou M, Sigala F, Skaltsounis AL, Tsantili-Kakoulidou A, Iliodromitis EK, Kremastinos DT, Mikros E.

NMR Biomed. 2009 Jul;22(6):585-92. doi: 10.1002/nbm.1370.

PMID:
19308947
10.

Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats.

Koti BC, Vishwanathswamy AH, Wagawade J, Thippeswamy AH.

Indian J Exp Biol. 2009 Jan;47(1):41-6.

PMID:
19317350
11.

Cardioprotective effects and mechanism of action of polyphenols extracted from propolis against doxorubicin toxicity.

Alyane M, Kebsa LB, Boussenane H, Rouibah H, Lahouel M.

Pak J Pharm Sci. 2008 Jul;21(3):201-9.

PMID:
18614413
12.

Cytoprotective role of Phyllanthus urinaria L. and glutathione-S transferase Pi in doxorubicin-induced toxicity in H9c2 cells.

Chularojmontri L, Ihara Y, Muroi E, Goto S, Kondo T, Wattanapitayakul SK.

J Med Assoc Thai. 2009 Jun;92 Suppl 3:S43-51.

PMID:
19705546
13.

PROTECTIVE EFFECT OF LACTUCA SERRIOLA ON DOXORUBICIN-INDUCED TOXICITY IN H9C2 CELLS.

Hosseini A, Mahdian D.

Acta Pol Pharm. 2016 May-Jun;73(3):659-66.

PMID:
27476284
14.

Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity.

Xin YF, Zhou GL, Shen M, Chen YX, Liu SP, Chen GC, Chen H, You ZQ, Xuan YX.

Basic Clin Pharmacol Toxicol. 2007 Dec;101(6):421-6. Epub 2007 Oct 25.

15.

Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.

van Acker SA, Boven E, Kuiper K, van den Berg DJ, Grimbergen JA, Kramer K, Bast A, van der Vijgh WJ.

Clin Cancer Res. 1997 Oct;3(10):1747-54.

16.

Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusion in vitro.

Chahine N, Nader M, Duca L, Martiny L, Chahine R.

Drug Chem Toxicol. 2016;39(1):87-96. doi: 10.3109/01480545.2015.1036281. Epub 2015 Apr 17.

PMID:
25885550
17.

Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation.

Kim DS, Woo ER, Chae SW, Ha KC, Lee GH, Hong ST, Kwon DY, Kim MS, Jung YK, Kim HM, Kim HK, Kim HR, Chae HJ.

Life Sci. 2007 Jan 2;80(4):314-23. Epub 2006 Sep 26.

PMID:
17034819
18.

The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.

Bruynzeel AM, Mul PP, Berkhof J, Bast A, Niessen HW, van der Vijgh WJ.

Cancer Chemother Pharmacol. 2006 Nov;58(5):699-702. Epub 2006 Mar 25.

PMID:
16565833
19.

Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro.

Liu Z, Song XD, Xin Y, Wang XJ, Yu H, Bai YY, Liu JH, Zhang CN, Hui RT.

Chin Med J (Engl). 2009 Nov 5;122(21):2652-6.

PMID:
19951587
20.

Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity.

Kim DS, Kim HR, Woo ER, Kwon DY, Kim MS, Chae SW, Chae HJ.

Eur J Pharmacol. 2006 Jul 10;541(1-2):24-32. Epub 2006 May 9.

PMID:
16780832

Supplemental Content

Support Center